WEC
NEOS

Winslow Evans & Crocker’s Neos Therapeutics, Inc NEOS Stock Holding History

Winslow Evans & Crocker’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$2K Buy
+3,000
New +$1.85K ﹤0.01% 1259

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winslow Evans & Crocker's NEOS Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in Neos Therapeutics, Inc (NEOS) in Q4 2020: 3,000 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1259 among its holdings.

37 funds tracked by Wall St. Rank hold NEOS as of Q4 2020.

  • Winslow Evans & Crocker held 3,000 shares of Neos Therapeutics, Inc worth $2K as of Q4 2020.
  • Neos Therapeutics, Inc was a new Winslow Evans & Crocker position in Q4 2020.
  • Neos Therapeutics, Inc made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1259 holding.
  • 37 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.